Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.

Szczegóły
Abstrakt

Tytuł:: Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.
Autorzy:: Kotepui KU; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Medical Technology Program, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat 80161, Thailand.
Obchoei S; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Department of Biochemistry, Faculty of Science, Prince of Songkla University, Songkhla 90110, Thailand.
Vaeteewoottacharn K; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Okada S; Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection & Graduate School of Medical Sciences, Kumamoto University, 860-0811, Japan.
Wongkham S; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Sawanyawisuth K; Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.; Center for Translational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Źródło:: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2022 Feb 01; Vol. 23 (2), pp. 715-721. Date of Electronic Publication: 2022 Feb 01.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Bangkok : Asian Pacific Organization for Cancer Prevention,
MeSH Terms:: Annexin A1/*genetics
Bile Duct Neoplasms/*genetics
Cholangiocarcinoma/*genetics
Neoplasm Metastasis/*genetics
Bile Ducts/metabolism ; Biomarkers, Tumor/genetics ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Humans ; Immunohistochemistry ; Lymphatic Metastasis/genetics ; Neoplasm Invasiveness/genetics ; Prognosis
References:: Biochem Biophys Res Commun. 2006 Jul 7;345(3):1022-32. (PMID: 16712791)
Asian Pac J Cancer Prev. 2013;14(6):3565-8. (PMID: 23886146)
J Exp Clin Cancer Res. 2012 Aug 28;31:70. (PMID: 22929401)
Clin Exp Metastasis. 1998 Feb;16(2):113-21. (PMID: 9514092)
FASEB J. 2007 Apr;21(4):968-75. (PMID: 17215481)
J Cancer. 2021 Jan 1;12(5):1295-1306. (PMID: 33531975)
Nat Protoc. 2006;1(5):2315-9. (PMID: 17406473)
Oncol Rep. 2015 Mar;33(3):1064-70. (PMID: 25592491)
Int J Mol Med. 2017 Feb;39(2):357-363. (PMID: 28035369)
Breast Cancer Res Treat. 2011 Aug;128(3):657-66. (PMID: 20821046)
Asian Pac J Cancer Prev. 2016;17(1):401-6. (PMID: 26838246)
Oncogene. 2011 Jul 14;30(28):3174-85. (PMID: 21383699)
World J Gastroenterol. 2010 Oct 7;16(37):4670-6. (PMID: 20872967)
Biochem Biophys Res Commun. 2012 Jun 22;423(1):188-94. (PMID: 22640735)
Nature. 1970 Aug 15;227(5259):680-5. (PMID: 5432063)
Cell Signal. 2013 Oct;25(10):1962-9. (PMID: 23727357)
J Biol Chem. 2006 Jul 14;281(28):19588-99. (PMID: 16675446)
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6340-5. (PMID: 20308542)
Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
Oncol Lett. 2015 Jan;9(1):3-8. (PMID: 25435926)
Oncol Rep. 2016 Sep;36(3):1435-46. (PMID: 27461717)
FASEB J. 2011 Feb;25(2):483-96. (PMID: 20930115)
Exp Ther Med. 2011 Mar;2(2):239-243. (PMID: 22977491)
PLoS One. 2014 Dec 09;9(12):e111317. (PMID: 25490767)
BMC Cancer. 2014 Dec 16;14:961. (PMID: 25510623)
World J Gastroenterol. 2013 Apr 28;19(16):2456-65. (PMID: 23674846)
Clin Cancer Res. 2006 Aug 1;12(15):4598-604. (PMID: 16899607)
Int J Mol Sci. 2018 Dec 04;19(12):. (PMID: 30518142)
Clin Cancer Res. 2002 Jan;8(1):117-23. (PMID: 11801547)
World J Gastroenterol. 2017 Oct 14;23(38):7009-7015. (PMID: 29097873)
Contributed Indexing:: Keywords: ANXA1; Annexin A1; Metastasis; cholangiocarcinoma
Substance Nomenclature:: 0 (ANXA1 protein, human)
0 (Annexin A1)
0 (Biomarkers, Tumor)
Entry Date(s):: Date Created: 20220228 Date Completed: 20220308 Latest Revision: 20220716
Update Code:: 20240104
PubMed Central ID:: PMC9272612
DOI:: 10.31557/APJCP.2022.23.2.715
PMID:: 35225485
: Czasopismo naukowe

Full Text Finder

Objective: Annexin A1 (ANXA1) is a calcium-dependent phospholipid-binding protein which contributes to proliferation, cancer progression and metastasis. Overexpression of ANXA1 is closely associated with metastasis in numerous types of cancer. Cholangiocarcinoma (CCA) is a bile-duct cancer which has high rates of metastasis. Previously, we demonstrated up-regulation of ANXA1 in a highly metastatic CCA cell line (KKU-213AL5). Here, we investigated the functions of ANXA1 in the progression of CCA cell lines and evaluated its clinical impacts in human CCA tissues. Methods: Effects of ANXA1 on metastatic potential of CCA cell lines were evaluated using cell-proliferation, clonogenic, migration and invasion assays. The expression of ANXA1 in 44 intrahepatic human CCA tissues was investigated using immunohistochemistry (IHC). The association of ANXA1 with clinicopathological features of CCA patients was analyzed.
Results: Silencing of ANXA1 expression using siRNA significantly decreased cell proliferation, colony formation, cell migration and invasion in the KKU-213AL5 cell line. IHC results showed low expression of ANXA1 in normal bile ducts in the non-tumor area. In contrast, high expression of ANXA1 in human CCA tissues was associated with advanced tumor stage, tumor size and presence of lymph-node metastasis.
Conclusion: These findings strongly imply that ANXA1 contributes to the progression of CCA. ANXA1 can serve as a potential prognostic marker for CCA. Ablation of ANXA1 action may be an alternative strategy to prevent metastasis of CCA.

Informacja